ISTH | P | JSTH | P | JMHLW | P | JAAM | P | |
---|---|---|---|---|---|---|---|---|
PLT (× 103/μl) | 100 ≧ > 50 | 1 | 120 ≧ > 80 | 1 | 120 ≧ > 80 | 1 | 120 ≧ > 8.0 | 1 |
50 ≧ | 2 | 80 ≧ > 50 | 2 | 80 ≧ > 50 | 2 | |||
50 ≧ | 3 | 50 ≧ | 3 | 80 ≧ | 3 | |||
Reduction of PLT | 30% | 1* | 30% | 1* | ||||
50% | 3* | |||||||
Prothrombin time ratio or Prolongation (s) | 3 ≦ < 6.0 | 1 | 1.25 ≦ < 1.67 | 1 | 1.25 ≦ < 1.67 | 1 | 1.2 ≦ | 1 |
6 ≦ | 2 | 1.67 ≦ | 2 | 1.67 ≦ | 2 | |||
Fibrinogen (g/L) | 1.0 ≧ | 1 | 1.5 ≧ > 1.0 | 1 | ||||
1.0 ≧ | 2 | |||||||
Fibrin related markers, FDP (μg/ml) | 10 ≦ < 20 | 1 | 10 ≦ < 20 | 1 | 10 ≦ < 25 | 1 | ||
Increase | 2 | 20 ≦ < 40 | 2 | 20 ≦ < 40 | 2 | |||
Markedly increase | 3 | 40 ≦ | 3 | 40 ≦ | 3 | 25 ≦ | 3 | |
Antithrombin | <  70% | 1 | ||||||
TAT or SF | 2 fold higher of NR | |||||||
Underlying diseases | Positive | 1 | ||||||
Bleeding | Positive | 1 | ||||||
OF due to thrombosis | Positive | 1 | ||||||
SIRS | Positive | 1 | ||||||
DIC | 5 ≦ | 5 ≦ | 7 ≦ | 4 ≦ |